Correction: The key cellular senescence related molecule RRM2 regulates prostate cancer progression and resistance to docetaxel treatment

被引:0
|
作者
Bisheng Cheng
Lingfeng Li
Yongxin Wu
Tianlong Luo
Chen Tang
Qiong Wang
Qianghua Zhou
Jilin Wu
Yiming Lai
Dingjun Zhu
Tao Du
Hai Huang
机构
[1] Sun Yat-Sen University,Department of Urology, Sun Yat
[2] Sun Yat-Sen University,Sen Memorial Hospital
[3] Sun Yat-Sen University,Guangdong Provincial Key Laboratory of Malignant Tumor Epigenetics and Gene Regulation, Sun Yat
[4] The Sixth Affiliated Hospital of Guangzhou Medical University,Sen Memorial Hospital
[5] Qingyuan People?s Hospital,Guangdong Provincial Clinical Research Center for Urological Diseases, Sun Yat
[6] Southern Medical University,Sen Memorial Hospital
[7] Sun Yat-Sen University,Department of Urology
关键词
D O I
10.1186/s13578-023-01178-1
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 14 条
  • [1] The key cellular senescence related molecule RRM2 regulates prostate cancer progression and resistance to docetaxel treatment
    Bisheng Cheng
    Lingfeng Li
    Yongxin Wu
    Tianlong Luo
    Chen Tang
    Qiong Wang
    Qianghua Zhou
    Jilin Wu
    Yiming Lai
    Dingjun Zhu
    Tao Du
    Hai Huang
    Cell & Bioscience, 13
  • [2] The key cellular senescence related molecule RRM2 regulates prostate cancer progression and resistance to docetaxel treatment
    Cheng, Bisheng
    Li, Lingfeng
    Wu, Yongxin
    Luo, Tianlong
    Tang, Chen
    Wang, Qiong
    Zhou, Qianghua
    Wu, Jilin
    Lai, Yiming
    Zhu, Dingjun
    Du, Tao
    Huang, Hai
    CELL AND BIOSCIENCE, 2023, 13 (01):
  • [3] Cellular Constituents of the Prostate Stroma: Key Contributors to Prostate Cancer Progression and Therapy Resistance
    Levesque, Christine
    Nelson, Peter S.
    COLD SPRING HARBOR PERSPECTIVES IN MEDICINE, 2018, 8 (08):
  • [4] A new perspective on prostate cancer treatment: the interplay between cellular senescence and treatment resistance
    Xu, Meng-Yao
    Xia, Zhi-Yu
    Sun, Jian-Xuan
    Liu, Chen-Qian
    An, Ye
    Xu, Jin-Zhou
    Zhang, Si-Han
    Zhong, Xing-Yu
    Zeng, Na
    Ma, Si-Yang
    He, Hao-Dong
    Wang, Shao-Gang
    Xia, Qi-Dong
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [5] LncRNA TTN-AS1 Regulates miR-524-5p and RRM2 to Promote Breast Cancer Progression
    Feng, Hui
    Wang, Qi
    Xiao, Wenjing
    Zhang, Biyuan
    Jin, Yonglong
    Lu, Haijun
    ONCOTARGETS AND THERAPY, 2020, 13 : 4799 - 4811
  • [6] Transcriptional and post-transcriptional regulation of ribonucleotide reductase (RRM2) control its oncogenic role in prostate cancer progression.
    Mazzu, Ying Zhang
    Armenia, Joshua
    Chakraborty, Goutam
    Yoshikawa, Yuki
    Gerke, Travis A.
    Atiq, Mohammad Omar
    Stopsack, Konrad Hermann
    Komura, Kazumasa
    Lee, Gwo-Shu Mary
    Mucci, Lorelei A.
    Kantoff, Philip W.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [7] MicroRNA-122 regulates docetaxel resistance of prostate cancer cells by regulating PKM2
    Zhu, Zhirong
    Tang, Guiliang
    Yan, Jiajun
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2020, 20 (06)
  • [8] A cellular senescence-related gene prognostic index for biochemical recurrence and drug resistance in patients with prostate cancer
    Feng, Dechao
    Shi, Xu
    You, Jia
    Xiong, Qiao
    Zhu, Weizhen
    Wei, Qiang
    Yang, Lu
    AMERICAN JOURNAL OF CANCER RESEARCH, 2022, 12 (08): : 3811 - 3828
  • [9] CaMKK2 regulates cellular proliferation and androgen receptor activity during prostate cancer progression
    Karacosta, Loukia Georgiou
    Foster, Barbara A.
    Azabdaftari, Gissou
    Feliciano, David M.
    Edelman, Arthur M.
    FASEB JOURNAL, 2012, 26
  • [10] Correction: Corrigendum: TET2 repression by androgen hormone regulates global hydroxymethylation status and prostate cancer progression
    Ken-ichi Takayama
    Aya Misawa
    Takashi Suzuki
    Kiyoshi Takagi
    Yoshihide Hayashizaki
    Tetsuya Fujimura
    Yukio Homma
    Satoru Takahashi
    Tomohiko Urano
    Satoshi Inoue
    Nature Communications, 6